Jay M Short Phd insider trades
Open-market stock purchases and sales by Jay M Short Phd, Chief Executive Officer at BioAtla, Inc, from SEC Form 4 filings since Jun 3, 2010.
Track record: 0% of 5 scored buys are up 5% or more since purchase, averaging -41%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 31, 2026 | BCAB BioAtla, Inc | Sold (not open market) | $438 |
| May 31, 2026 | BCAB BioAtla, Inc | Sold (not open market) | $1K |
| Mar 12, 2026 | BCAB BioAtla, Inc | Sold (not open market) | $107 |
| Mar 11, 2026 | BCAB BioAtla, Inc | Bought (not open market) | — |
| Feb 28, 2026 | BCAB BioAtla, Inc | Sold (not open market) | $1.9K |
| Nov 30, 2025 | BCAB BioAtla, Inc | Sold (not open market) | $5.7K |